Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Axial Spondyloarthritis Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Axial Spondyloarthritis Drugsmarket, defines the market attractiveness level of Axial Spondyloarthritis Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Axial Spondyloarthritis Drugs industry, describes the types of Axial Spondyloarthritis Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Axial Spondyloarthritis Drugs market and the development prospects and opportunities of Axial Spondyloarthritis Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Axial Spondyloarthritis Drugs market in Chapter 13.
By Player:
UCB SA
Sandoz International GmbH
Eli Lilly and Company
Sun Pharma Advanced Research Company Ltd
AstraZeneca Plc
Panacea Biotec Ltd
Novartis AG
Johnson & Johnson
By Type:
Certolizumab Pegol
Etanercept Biosimilar
Ixekizumab
Secukinumab
Others
By End-User:
Clinic
Hospital
Home Care
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Axial Spondyloarthritis Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Axial Spondyloarthritis Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Axial Spondyloarthritis Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Axial Spondyloarthritis Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Axial Spondyloarthritis Drugs Market Analysis and Outlook to 2022
-
7.1 Global Axial Spondyloarthritis Drugs Consumption (2017-2022)
-
7.2 United States Axial Spondyloarthritis Drugs Consumption (2017-2022)
-
7.3 Europe Axial Spondyloarthritis Drugs Consumption (2017-2022)
-
7.4 China Axial Spondyloarthritis Drugs Consumption (2017-2022)
-
7.5 Japan Axial Spondyloarthritis Drugs Consumption (2017-2022)
-
7.6 India Axial Spondyloarthritis Drugs Consumption (2017-2022)
-
7.7 South Korea Axial Spondyloarthritis Drugs Consumption (2017-2022)
8 Region and Country-wise Axial Spondyloarthritis Drugs Market Analysis and Outlook to 2028
-
8.1 Global Axial Spondyloarthritis Drugs Consumption Forecast (2022-2028)
-
8.2 United States Axial Spondyloarthritis Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Axial Spondyloarthritis Drugs Consumption Forecast (2022-2028)
-
8.4 China Axial Spondyloarthritis Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Axial Spondyloarthritis Drugs Consumption Forecast (2022-2028)
-
8.6 India Axial Spondyloarthritis Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Axial Spondyloarthritis Drugs Consumption Forecast (2022-2028)
9 Global Axial Spondyloarthritis Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Axial Spondyloarthritis Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Certolizumab Pegol Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Etanercept Biosimilar Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Ixekizumab Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Secukinumab Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Axial Spondyloarthritis Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Home Care Consumption and Growth Rate (2017-2022)
10 Global Axial Spondyloarthritis Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Axial Spondyloarthritis Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Certolizumab Pegol Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Etanercept Biosimilar Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Ixekizumab Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Secukinumab Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Axial Spondyloarthritis Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Home Care Consumption Forecast and Growth Rate (2022-2028)
11 Global Axial Spondyloarthritis Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Axial Spondyloarthritis Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Axial Spondyloarthritis Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Axial Spondyloarthritis Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Axial Spondyloarthritis Drugs Market Competitive Analysis
-
14.1 UCB SA
-
14.1.1 UCB SA Company Details
-
14.1.2 UCB SA Axial Spondyloarthritis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 UCB SA Axial Spondyloarthritis Drugs Product and Service
-
14.2 Sandoz International GmbH
-
14.2.1 Sandoz International GmbH Company Details
-
14.2.2 Sandoz International GmbH Axial Spondyloarthritis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Sandoz International GmbH Axial Spondyloarthritis Drugs Product and Service
-
14.3 Eli Lilly and Company
-
14.3.1 Eli Lilly and Company Company Details
-
14.3.2 Eli Lilly and Company Axial Spondyloarthritis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Eli Lilly and Company Axial Spondyloarthritis Drugs Product and Service
-
14.4 Sun Pharma Advanced Research Company Ltd
-
14.4.1 Sun Pharma Advanced Research Company Ltd Company Details
-
14.4.2 Sun Pharma Advanced Research Company Ltd Axial Spondyloarthritis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Sun Pharma Advanced Research Company Ltd Axial Spondyloarthritis Drugs Product and Service
-
14.5 AstraZeneca Plc
-
14.5.1 AstraZeneca Plc Company Details
-
14.5.2 AstraZeneca Plc Axial Spondyloarthritis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 AstraZeneca Plc Axial Spondyloarthritis Drugs Product and Service
-
14.6 Panacea Biotec Ltd
-
14.6.1 Panacea Biotec Ltd Company Details
-
14.6.2 Panacea Biotec Ltd Axial Spondyloarthritis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Panacea Biotec Ltd Axial Spondyloarthritis Drugs Product and Service
-
14.7 Novartis AG
-
14.7.1 Novartis AG Company Details
-
14.7.2 Novartis AG Axial Spondyloarthritis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Novartis AG Axial Spondyloarthritis Drugs Product and Service
-
14.8 Johnson & Johnson
-
14.8.1 Johnson & Johnson Company Details
-
14.8.2 Johnson & Johnson Axial Spondyloarthritis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Johnson & Johnson Axial Spondyloarthritis Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Axial Spondyloarthritis Drugs
-
Figure Axial Spondyloarthritis Drugs Picture
-
Table Global Axial Spondyloarthritis Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Axial Spondyloarthritis Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Axial Spondyloarthritis Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Axial Spondyloarthritis Drugs Consumption by Country (2017-2022)
-
Figure United States Axial Spondyloarthritis Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Axial Spondyloarthritis Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Axial Spondyloarthritis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Axial Spondyloarthritis Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Axial Spondyloarthritis Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Axial Spondyloarthritis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Axial Spondyloarthritis Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Axial Spondyloarthritis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Axial Spondyloarthritis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Axial Spondyloarthritis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Axial Spondyloarthritis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Axial Spondyloarthritis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Axial Spondyloarthritis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Certolizumab Pegol Consumption and Growth Rate (2017-2022)
-
Figure Global Etanercept Biosimilar Consumption and Growth Rate (2017-2022)
-
Figure Global Ixekizumab Consumption and Growth Rate (2017-2022)
-
Figure Global Secukinumab Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Home Care Consumption and Growth Rate (2017-2022)
-
Figure Global Certolizumab Pegol Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Etanercept Biosimilar Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ixekizumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Secukinumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Home Care Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Axial Spondyloarthritis Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Axial Spondyloarthritis Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table UCB SA (Foundation Year, Company Profile and etc.)
-
Table UCB SA Axial Spondyloarthritis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table UCB SA Axial Spondyloarthritis Drugs Product and Service
-
Table Sandoz International GmbH (Foundation Year, Company Profile and etc.)
-
Table Sandoz International GmbH Axial Spondyloarthritis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sandoz International GmbH Axial Spondyloarthritis Drugs Product and Service
-
Table Eli Lilly and Company (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly and Company Axial Spondyloarthritis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly and Company Axial Spondyloarthritis Drugs Product and Service
-
Table Sun Pharma Advanced Research Company Ltd (Foundation Year, Company Profile and etc.)
-
Table Sun Pharma Advanced Research Company Ltd Axial Spondyloarthritis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sun Pharma Advanced Research Company Ltd Axial Spondyloarthritis Drugs Product and Service
-
Table AstraZeneca Plc (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Plc Axial Spondyloarthritis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Plc Axial Spondyloarthritis Drugs Product and Service
-
Table Panacea Biotec Ltd (Foundation Year, Company Profile and etc.)
-
Table Panacea Biotec Ltd Axial Spondyloarthritis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Panacea Biotec Ltd Axial Spondyloarthritis Drugs Product and Service
-
Table Novartis AG (Foundation Year, Company Profile and etc.)
-
Table Novartis AG Axial Spondyloarthritis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Axial Spondyloarthritis Drugs Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Axial Spondyloarthritis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Axial Spondyloarthritis Drugs Product and Service
-
